<DOC>
	<DOC>NCT02082262</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of AGN-229666 for the treatment of seasonal or perennial allergic conjunctivitis.</brief_summary>
	<brief_title>AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Japanese patients living in Japan with allergic conjunctivitis with itching and redness Able and willing to discontinue wearing any contact lenses during the study period. Eye surgical intervention and/or a history of refractive surgery within 6 months History of retinal detachment, diabetic retinopathy, or progressive retinal disease Presence of active eye infection (bacterial, viral, or fungal) History of an eye herpetic infection Use of corticosteroids within 6 months or anticipated use during the study.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>